These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32220947)

  • 1. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU).
    Casali PG; Trama A
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32220947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.
    Ferrari A; Brecht IB; Gatta G; Schneider DT; Orbach D; Cecchetto G; Godzinski J; Reguerre Y; Bien E; Stachowicz-Stencel T; Ost M; Magni C; Kearns P; Vassal G; Massimino M; Biondi A; Bisogno G; Trama A
    Eur J Cancer; 2019 Mar; 110():120-126. PubMed ID: 30785015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of rare cancers and inequalities in oncologic outcomes.
    Gatta G; Trama A; Capocaccia R;
    Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia.
    Matsuda T; Won YJ; Chun-Ju Chiang R; Lim J; Saika K; Fukui K; Lee WC; Botta L; Bernasconi A; Trama A
    Cancer Epidemiol; 2020 Aug; 67():101702. PubMed ID: 32535408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
    Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
    Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.
    Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R;
    Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of rare cancers in Europe.
    Gatta G; Capocaccia R; Trama A; Martínez-García C;
    Adv Exp Med Biol; 2010; 686():285-303. PubMed ID: 20824452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare cancers are not so rare: the rare cancer burden in Europe.
    Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R;
    Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of rare cancer in Japan: application of the RARECARE definition.
    Tamaki T; Dong Y; Ohno Y; Sobue T; Nishimoto H; Shibata A
    Cancer Epidemiol; 2014 Oct; 38(5):490-5. PubMed ID: 25155209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare cancers in The Netherlands: a population-based study.
    van der Zwan JM; van Dijk BAC; Visser O; van Krieken HJHJM; Capocaccia R; Siesling S
    Eur J Cancer Prev; 2018 Jul; 27(4):384-390. PubMed ID: 25969132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.
    Trama A; Mallone S; Ferretti S; Meduri F; Capocaccia R; Gatta G;
    Tumori; 2012; 98(5):550-8. PubMed ID: 23235748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
    Stacchiotti S; Frezza AM; Blay JY; Baldini EH; Bonvalot S; Bovée JVMG; Callegaro D; Casali PG; Chiang RC; Demetri GD; Demicco EG; Desai J; Eriksson M; Gelderblom H; George S; Gounder MM; Gronchi A; Gupta A; Haas RL; Hayes-Jardon A; Hohenberger P; Jones KB; Jones RL; Kasper B; Kawai A; Kirsch DG; Kleinerman ES; Le Cesne A; Lim J; Chirlaque López MD; Maestro R; Marcos-Gragera R; Martin Broto J; Matsuda T; Mir O; Patel SR; Raut CP; Razak ARA; Reed DR; Rutkowski P; Sanfilippo RG; Sbaraglia M; Schaefer IM; Strauss DC; Sundby Hall K; Tap WD; Thomas DM; van der Graaf WTA; van Houdt WJ; Visser O; von Mehren M; Wagner AJ; Wilky BA; Won YJ; Fletcher CDM; Dei Tos AP; Trama A
    Cancer; 2021 Aug; 127(16):2934-2942. PubMed ID: 33910263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare cancers of the head and neck area in Europe.
    Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L;
    Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data quality in rare cancers registration: the report of the RARECARE data quality study.
    Trama A; Marcos-Gragera R; Sánchez Pérez MJ; van der Zwan JM; Ardanaz E; Bouchardy C; Melchor JM; Martinez C; Capocaccia R; Vicentini M; Siesling S; Gatta G;
    Tumori; 2017 Jan; 103(1):22-32. PubMed ID: 27716878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problem of rare cancers.].
    Casali PG; Provenzano S; Trama A
    Recenti Prog Med; 2022; 113(7):430-433. PubMed ID: 35852078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare tumors: A comprehensive analysis of cancer.
    Bondei Irina T; Ofelia S; Todor N; Viorica Magdalena N
    J BUON; 2019; 24(5):2173-2179. PubMed ID: 31786892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of endocrine organs: results of the RARECARE project.
    van der Zwan JM; Mallone S; van Dijk B; Bielska-Lasota M; Otter R; Foschi R; Baudin E; Links TP;
    Eur J Cancer; 2012 Sep; 48(13):1923-31. PubMed ID: 22361014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of rare cancers in the city of São Paulo, Brazil.
    Bustamante-Teixeira MT; Latorre MDRDO; Guerra MR; Tanaka LF; Botta L; Trama A; Gatta G
    Tumori; 2019 Feb; 105(1):22-30. PubMed ID: 30700226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.